Non-Invasive Prenatal Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing healthcare expenditure and rising demand for early and non-invasive fetal testing procedures are some of the factors driving the growth of this market.
Non-Invasive Prenatal Testing Market is valued at USD 1.32 Billion in 2018 and expected to reach USD 3.71 Billion by 2025 with the CAGR of 15.9% over the forecast period.
Scope of Global Non-Invasive Prenatal Testing Market Report–
Non-invasive prenatal testing is also known as non-invasive prenatal screening, which is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward Syndrome), trisomy 13 (Patau Syndrome), and monosomy X (Turner Syndrome). It can also detect the blood group and rhesus actor of the fetus. Major non-invasive prenatal tests currently available in the global market are MAterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67414&RequestType=Sample
Global non-invasive prenatal testing market report is segmented on the basis of product, method, application, end-users and region & country level. Based on product, the market is classified as consumables and instruments. Based upon method, the market is classified into ultrasound detection, biochemical screening tests, cell-free DNA in maternal plasma tests, and fetal cells in maternal blood tests. Based upon application, global non-invasive Prenatal testing market is classified as trisomy, microdeletion syndrome, and others. Based upon end-users, global non-invasive Prenatal testing market is classified into diagnostics laboratories and hospitals.
The regions covered in This Non-Invasive Prenatal Testing Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of non-invasive prenatal testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Non-Invasive Prenatal Testing Market Report-
Global non-invasive Prenatal testing market report covers prominent players like GE Healthcare (General Electric Company), Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen N.V., Agilent Technologies, Inc., Beijing Genomics Institute, LifeCell International, and others.
LifeCell Launched ‘Pentastic’- a Prenatal Test to Detect Genetic Abnormalities in Fetus
On May 31st, 2018; LifeCell, India’s premier mother and baby diagnostics company and stem cell bank, launched ‘Pentastic’ – an ultrasound and biochemistry based blood test undertaken in the first trimester of pregnancy between 11 to 13 weeks, 6 days to screen for genetic abnormalities, structural malformations in the fetus and serious high blood pressure in pregnancy. Compared to conventional screening tests that use only 2 analytes [PAPP-A + free hCGß], the new Pentastic test incorporates 5 analytes [PAPP-A + free hCGß + AFP + Inhibin-A + PIGF] to predict the risk. Addition of these new analytes can significantly improve the detection of these abnormalities whilst simultaneously lowering the number of false alarms raised.This would lead to substantial improvements in health outcomes whilst providing a higher level of reassurance for expectant parents.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67414&RequestType=Methodology
Global Non-Invasive Prenatal Testing Market Dynamics–
Increasing reimbursement policies for the NIPT sector, increased shift from invasive methods to non-invasive methods and increasing average maternal age (associated with growth in the risk of chromosomal abnormalities in babies) foster the growth of the non-invasive prenatal testing market. For instance, in 2014, the International Society for Prenatal Diagnosis (ISPD) considered the offer of NIPT as a first-tier screening test for all pregnant women to be an “appropriate” option. In addition, Increasing healthcare expenditure and rising demand for early and non-invasive fetal testing procedures are also supplementing the growth of this market. However, lack of skilled professionals as well as strict regulatory guidelines and ethical hurdles slow down the process of approvals and marketing, thus restricting the market growth. Moreover, untapped emergence of new market in Asia-Pacific makes a way for growth opportunities for this market within the forecast period.
North America is Expected to Dominate the Global Non-Invasive Prenatal Testing Market
North America is expected to dominate the global non-invasive prenatal testing market due to higher rate of adoption of non-invasive prenatal testing; rising cases of down’s syndrome, strong healthcare infrastructure, and presence of key companies in this region. According to CDC, about 1 out of every 1,200 people (children, teens, and adults) living in the United States had Down syndrome. This means that about 83,000 children and teenagers were living with Down syndrome.
Asia Pacific is expected to witness a lucrative growth in this market due to the presence of significant developments by China and Japan for technological integration of NGS methodologies, and the development of healthcare, R&D and clinical development frameworks of emerging economies such as India and Australia in this region.
Key Benefits for Global Non-Invasive Prenatal Testing Market Report–
- Global Non-Invasive Prenatal Testing Market report covers in depth historical and forecast analysis.
- Global Non-Invasive Prenatal Testing Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Non-Invasive Prenatal Testing Market report helps to identify opportunities in market place.
- Global Non-Invasive Prenatal Testing Market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Non-Invasive-Prenatal-Testing-Market-Share/Summary
Global Non-Invasive Prenatal Testing Market Segmentation: –
- Assay Kits & Reagents
- Ultrasound Devices
- Next-Generation Sequencing Systems
- Polymerase Chain Reaction Instruments
- Other Instruments
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests analysis
- Microdeletion Syndrome
- Other Applications
- Diagnostic Laboratories
By Regional & Country Analysis:
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- The Middle East and Africa
- Rest of Middle East and Africa
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org